JAMA Oncol: Efficacy and safety of Pembrolizumab combined with concurrent chemoradiotherapy (cCRT) in the treatment of unresectable stage III NSCLC: KEYNOTE-799.
J Headache Pain: Effectiveness and Safety of Eprirenizumab in Preventing Chronic Migraine: Results of the PROMISE-2 Phase III Study
ASCO2021: Devaruzumab can improve the 5-year survival and progression-free survival of patients with unresectable stage III NSCLC
of stage III or IV ovarian cancer: a placebo-controlled randomized phase III study (IMagyn050/GOG 3015/ENGOT- OV39)
Aluminium-related products import and export data released in March 2021
"Lithium Thinking" China's "Membrane" Magical Future: Mingguan Leads Domestic Aluminium Plastic Film to be Independent and Controllable
Head-to-head superiority data presented in the global phase III head-to-head study of Zebutinib confirms the efficacy and safety advantages
), the efficacy and safety of platinum-based chemotherapy versus capecitabine: a randomized phase III study (ECOG-ACRIN EA1131)
Junshi PD-1 combined with chemotherapy for first-line esophageal squamous cell carcinoma phase III clinical reach the primary endpoint
Watson Biotechnology's mRNA COVID-19 vaccine is about to start phase III clinical trials
Donghua Energy Ningbo Comprehensive Utilization of Alkane Resources (Phase III) Project puts
The first domestic hormone replacement therapy for the treatment of hypoparathyroidism was approved for Phase III...
Zhongke Refinery's ammonium sulfate output hits a record
The Ningbo Alkane Resource Comprehensive Utilization (Phase III) Project was put into operation
Interview with Professor Xiaoling Cai: How far is it from us to be approved to enter Phase III clinical, oral insulin?
Successful Chinese Phase III Bridging Trial of New Antibiotics
JAMA blockbuster: Sinopharm releases phase III clinical data of the world's first inactivated COVID-19 vaccine
JTO: Durvalumab in the treatment of NSCLE patients with stage III EGFR mutations after concurrent radiotherapy and chemotherapy
Pioneer Pharmaceuticals completes the first patient administration in the treatment of COVID-19 in the U.S. Phase III clinical trial with procrulamide
The reasons for the suspension of Roche's tominersen phase III trial were repeated, and analysts put forward four hypotheses